Figure 2.
Stakeholders involved and agenda with discussion points. Per condition relevant changes were made to the composition of the group, for example including a metabolic paediatrician or a neuromuscular paediatrician. ALD, X-linked adrenoleukodystrophy; BKT, methyl-acetoacetyl-CoA thiolase deficiency, ketothiolase deficiency; CACT, carnitine-acylcarnitine translocase deficiency; CPT1, carnitine palmitoyltransferase deficiency type 1; CPT2, carnitine palmitoyltransferase deficiency type 2; GALK, galactokinase deficiency; GAMT, guanidinoacetate methyltransferase deficiency; MMA, methylmalonic acidemia; MPS I, mucopolysaccharidosis type 1; PA, propionic acidemia; OCTN2, organic cation transporter 2 deficiency; RIVM, National Institute for Public Health and the Environment.
